基本資料
種類: ETF
費用比率%: 0.57
資產淨值: 105.08
成立日期: 23/06/2005
 
分析
市值分佈:
73.68%
大市值
24.17%
中市值
2.09%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 04/04/2026 06:03) 總持有投資項目: 29  
0%
 
100%
     10大 (47.58%)
代號 名稱 佔比% 持有日期
PFEPfizer5.5331/03/2026
JNJJohnson & Johnson5.3031/03/2026
MRKMerck & Co5.1831/03/2026
ABBVABBVIE5.0931/03/2026
GILDGilead Sciences5.0431/03/2026
AMGNAmgen4.9131/03/2026
ABTAbbott Laboratories4.7931/03/2026
LLYEli Lilly & Co4.7131/03/2026
UTHRUnited Therapeutics Corp3.7131/03/2026
LQDALiquidia Corp3.3331/03/2026
CORTCorcept Therapeutics3.2731/03/2026
JAZZJazz Pharmaceuticals plc3.2231/03/2026
LGNDLigand Pharmaceuticals3.1231/03/2026
ANIPANI Pharmaceuticals2.9731/03/2026
REGNRegeneron Pharmaceuticals2.9631/03/2026
INVAInnoviva2.9431/03/2026
HRMYHarmony Biosciences Holdings2.9431/03/2026
BMYBristol-Myers Squibb Co2.9131/03/2026
SUPNSupernus Pharmaceuticals2.8731/03/2026
TVTXTravere Therapeutics2.8531/03/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.